Relx (LON:REL) Hits New 52-Week High at $3,553.00

Relx Plc (LON:RELGet Free Report)’s stock price hit a new 52-week high during trading on Thursday . The stock traded as high as GBX 3,553 ($45.52) and last traded at GBX 3,550 ($45.48), with a volume of 24082609 shares trading hands. The stock had previously closed at GBX 3,521 ($45.11).

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on REL. Berenberg Bank downgraded Relx to a “hold” rating and boosted their price objective for the stock from GBX 3,300 ($42.28) to GBX 3,500 ($44.84) in a research report on Friday, March 29th. JPMorgan Chase & Co. lifted their target price on Relx from GBX 3,770 ($48.30) to GBX 4,100 ($52.53) and gave the company an “overweight” rating in a research note on Friday, February 16th.

View Our Latest Research Report on Relx

Relx Stock Performance

The stock has a market cap of £66.44 billion, a P/E ratio of 3,869.23, a PEG ratio of 3.83 and a beta of 0.46. The company has a debt-to-equity ratio of 188.92, a current ratio of 0.52 and a quick ratio of 0.45. The company has a fifty day moving average of GBX 3,385.63 and a 200 day moving average of GBX 3,290.94.

Insider Transactions at Relx

In other news, insider Alistair R. Cox bought 1,630 shares of the firm’s stock in a transaction that occurred on Thursday, April 25th. The stock was acquired at an average price of GBX 3,229 ($41.37) per share, with a total value of £52,632.70 ($67,434.59). Company insiders own 0.42% of the company’s stock.

Relx Company Profile

(Get Free Report)

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.

Read More

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.